GlassScriptPhysician profile
Ricardo D Silvera
NPI 1255667192
$3,215.99
in general payments reported to CMS, 2019-2025
20 companies · $867 in 2025
The $867 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $850 · 2022: $597 · 2023: $375 · 2024: $527 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,769.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $1,190.29 | 2021-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,139.98 | 2021-2025 | Relistor |
| Redhill Biopharma INC. | $165.13 | 2021-2022 | |
| Nevro Corp. | $105.43 | 2022-2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $93.49 | 2022 | |
| Averitas Pharma INC. | $87.61 | 2025 | Qutenza |
| Almatica Pharma LLC | $64.88 | 2021 | |
| Collegium Pharmaceutical, INC. | $57.64 | 2021-2025 | Xtampza |
| Horizon Therapeutics Plc | $46.25 | 2022 | |
| Boston Scientific Corporation | $43.98 | 2022 | |
| Valinor Pharma, LLC | $43.28 | 2023-2025 | Movantik |
| Kowa Pharmaceuticals America, INC. | $35.92 | 2022 | |
| Biodelivery Sciences International, INC. | $34.77 | 2021 | |
| Abbvie INC. | $23.12 | 2023 | |
| Electronic Waveform Lab, INC. | $21.25 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $18.92 | 2021 | |
| Globus Medical, INC. | $16.70 | 2025 | Senza |
| Medtronic, INC. | $13.55 | 2022 | |
| Hikma Pharmaceuticals USA | $12.04 | 2021 | |
| Forte Bio-Pharma LLC | $1.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Silvera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.